From: Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
No | Age/ gender | Risk factors | Time from diagnosis to shunt (m) | neurological deficit | antifungal therapy | Outcome 1Â m | |
---|---|---|---|---|---|---|---|
 | Before VPS | After VPS improved |  | ||||
 |  |  |  | VPSV |  |  |  |
1 | 38/M | Hepatitis B | 4 | H,VL,HL | H | AMBisome+Fluc+5FC | better |
2 | 36/M | Hepatitis B, Liver cirrhosis | 1.5 | H,VL,LOC | H,VL,LOC | AMB + Fluc+5FC | worse |
3 | 40/M | Diabetes mellitus | 3 | H/V | H | AMB + Fluc+5FC | better |
4 | 17/M |  | 3.5 | H/V,VL,LOC | H/V,VL,LOC | AMB + Fluc+5FC | better |
5 | 28/M | Â | 1.5 | H/V,VL | H,VL | Fluc+5FC | better |
6 | 53/M |  | 6 | V, LOC | V, LOC | AMB + Fluc+5FC | better |
7 | 27/M | pulmonary cryptococcosis | 3 | H/V,VL | H/V | AMB + Fluc+5FC | better |
8 | 21/M |  | 5 | H | H | AMB + Fluc+5FC | better |
9 | 31/M | Hepatitis B, Diabetes mellitus | 6 | H,VL | H,VL | Fluc+5FC | better |
10 | 19/M | AIHA | 4 | H/V,CO | H/V,CO | AMB + Fluc+5FC | better |
11 | 18/M | Hepatitis B | 2 | H/V | H/V | AMB + Fluc+5FC | better |
12 | 53/F |  | 3.5 | V,LOC | V,LOC | AMB + Fluc+5FC | better |
13 | 50/M | Hepatitis B | 6 | H,VL | H | Fluc+5FC | better |
 |  |  |  | VPSWOV |  |  |  |
14 | 41/F | pulmonary cryptococcosis | 4 | H/V | H | AMB + Fluc+5FC | better |
15 | 35/M |  | 3 | H/V,VL,LOC | H/V,VL,LOC | AMB + Fluc+5FC | better |
16 | 40/M | pulmonary cryptococcosis | 3 | H/V,VL,HL | H/V,VL | AMB + Fluc+5FC | better |
17 | 51/M | Diabetes mellitus | 0.5 | H/V,VL | H/V,VL | AMB + Fluc+5FC | better |
18 | 41/M |  | 2 | H,VL, CO | H,VL | AMB + Fluc+5FC | better |
19 | 61/F | Malignancy | 4 | H/V | H/V | Fluc+5FC | worse |
20 | 37/M | Hepatitis B | 2 | H/V,VL,HL | H/V,VL | AMB + Fluc+5FC | better |
21 | 55/F | SLE | 0.5 | H/V,VL | H/V,VL | Fluc+5FC | better |
22 | 17/M | pulmonary cryptococcosis | 1 | H/V,LOC | H/V,LOC | AMB + Fluc+5FC | better |
23 | 45/F | AIHA | 1 | H,VL,HL,LOC | H,VL | AMB + Fluc+5FC | NA |